Followers | 195 |
Posts | 24730 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Monday, February 12, 2024 8:14:18 PM
The reality is there is immense opportunity to stay independent, but the challenge is, they also need money to fund growth and expansion. So the temptation is always to pair up even now with deep pockets. Waiting too long to do it is difficult.
IBRX is not a big pharma and unfortunately, better products are often eclipsed by companies better positioned to market their own product. But I would expect that IBRX might very likely get a lot of interest. Over 80% of the shares are held by insiders. Makes it hard to buy without a very good offer.
There is a sizeable short position versus their actual float, shares available. So it could be difficult to cover. Most shares appear tightly held by a few holding 10% and more, totaling just over 80%.
Recent filings are interesting:
Ownership:
https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001326110
39% here:
https://www.sec.gov/Archives/edgar/data/1326110/000119312524001705/d47784dsc13da.htm
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1326110/000132611024000003/ibrx-20231229.htm
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1326110/000132611023000147/ibrx-20230930.htm
Last 10K: https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1326110/000132611023000018/ibrx-20221231.htm
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM